Psilocybin may present unique risks during the postpartum period, reveals study

Day 1 conference highlights include news from Moderna, BridgeBio

DRRA11 hours ago 0

FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease

DRRA11 hours ago 0

New data, nuances in managing resistant gram-negative infections

DRRA12 hours ago 0

New Year’s resolutions 2026: Lessons from colleagues

DRRA12 hours ago 0